- Report
- October 2023
- 184 Pages
Global
From €3408EUR$3,554USD£2,918GBP
€3786EUR$3,949USD£3,242GBP
- Report
- June 2023
- 275 Pages
Global
From €3835EUR$4,000USD£3,284GBP
€4794EUR$5,000USD£4,105GBP
- Report
- February 2023
- 175 Pages
Global
From €3835EUR$4,000USD£3,284GBP
€4794EUR$5,000USD£4,105GBP
- Report
- August 2023
- 175 Pages
Global
From €3835EUR$4,000USD£3,284GBP
€4794EUR$5,000USD£4,105GBP
- Report
- May 2023
- 250 Pages
Global
From €3835EUR$4,000USD£3,284GBP
€4794EUR$5,000USD£4,105GBP
- Report
- November 2023
- 150 Pages
Global
From €4650EUR$4,850USD£3,982GBP
- Report
- September 2023
- 110 Pages
Global
From €5705EUR$5,950USD£4,885GBP
- Report
- October 2023
- 198 Pages
Global
From €3408EUR$3,554USD£2,918GBP
€3786EUR$3,949USD£3,242GBP
- Report
- December 2023
- 182 Pages
Global
From €4746EUR$4,950USD£4,064GBP
- Report
- December 2023
- 192 Pages
Global
From €4746EUR$4,950USD£4,064GBP
- Report
- December 2023
- 173 Pages
Global
From €5226EUR$5,450USD£4,475GBP
- Report
- March 2023
- 106 Pages
Global
From €2396EUR$2,499USD£2,052GBP
- Report
- January 2023
- 184 Pages
Global
From €3038EUR$3,168USD£2,601GBP
€3452EUR$3,600USD£2,956GBP
- Report
- April 2023
- 120 Pages
Global
From €3871EUR$4,038USD£3,315GBP
€4554EUR$4,750USD£3,900GBP
- Report
- April 2023
- 116 Pages
Global
From €3871EUR$4,038USD£3,315GBP
€4554EUR$4,750USD£3,900GBP
- Report
- September 2023
- 182 Pages
Global
From €3054EUR$3,185USD£2,615GBP
€4363EUR$4,550USD£3,736GBP
- Report
- November 2023
- 30 Pages
Global
From €2109EUR$2,200USD£1,806GBP
€2637EUR$2,750USD£2,258GBP
- Report
- November 2023
- 30 Pages
Global
From €2109EUR$2,200USD£1,806GBP
€2637EUR$2,750USD£2,258GBP
- Clinical Trials
- July 2023
- 400 Pages
Global
From €3835EUR$4,000USD£3,284GBP
€4794EUR$5,000USD£4,105GBP
- Report
- May 2023
- 200 Pages
Global
From €5753EUR$6,000USD£4,926GBP
€7191EUR$7,500USD£6,158GBP

The Brain Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat brain cancer. Brain cancer is a type of cancer that affects the cells of the brain and can be caused by a variety of factors, including genetics, environmental exposure, and lifestyle. Brain cancer drugs are used to treat the symptoms of brain cancer, such as headaches, seizures, and nausea, as well as to slow the progression of the disease.
Brain cancer drugs are typically divided into two categories: chemotherapy and targeted therapy. Chemotherapy drugs are used to kill cancer cells, while targeted therapy drugs are designed to target specific cancer cells and stop them from growing. Both types of drugs are used in combination to treat brain cancer.
Some of the major companies in the Brain Cancer Drugs market include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and Roche. These companies are involved in the development and sale of drugs used to treat brain cancer, as well as in the research and development of new treatments. Show Less Read more